Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial)--rationale, design and first interim analysis.

Theiss HD, Brenner C, Engelmann MG, Zaruba MM, Huber B, Henschel V, Mansmann U, Wintersperger B, Reiser M, Steinbeck G, Franz WM.

Int J Cardiol. 2010 Nov 19;145(2):282-284. doi: 10.1016/j.ijcard.2009.09.555. Epub 2010 Jan 3.

PMID:
20051299
2.

G-CSF in patients suffering from late revascularised ST elevation myocardial infarction: final 1-year-results of the G-CSF-STEMI Trial.

Engelmann MG, Theiss HD, Theiss C, Henschel V, Huber A, Wintersperger BJ, Schoenberg SO, Steinbeck G, Franz WM.

Int J Cardiol. 2010 Oct 29;144(3):399-404. doi: 10.1016/j.ijcard.2009.04.047. Epub 2009 May 27.

PMID:
19477537
3.

Stem cell mobilisation for myocardial repair.

Brunner S, Engelmann MG, Franz WM.

Expert Opin Biol Ther. 2008 Nov;8(11):1675-90. doi: 10.1517/14712598.8.11.1675 . Review.

PMID:
18847304
4.

G-CSF in patients suffering from late revascularized ST elevation myocardial infarction: analysis on the timing of G-CSF administration.

Engelmann MG, Theiss HD, Theiss C, Huber A, Wintersperger BJ, Werle-Ruedinger AE, Schoenberg SO, Steinbeck G, Franz WM.

Exp Hematol. 2008 Jun;36(6):703-9. doi: 10.1016/j.exphem.2008.01.008. Epub 2008 Mar 17.

PMID:
18346835
5.

Thoracic mycotic pseudoaneurysm from Candida albicans infection.

Brunner S, Engelmann MG, Näbauer M.

Eur Heart J. 2008 Jun;29(12):1515. doi: 10.1093/eurheartj/ehm623. Epub 2008 Jan 5. No abstract available.

PMID:
18175772
6.

Small poly-L-lysines improve cationic lipid-mediated gene transfer in vascular cells in vitro and in vivo.

Golda A, Pelisek J, Klocke R, Engelmann MG, Rolland PH, Mekkaoui C, Nikol S.

J Vasc Res. 2007;44(4):273-82. Epub 2007 Mar 30.

PMID:
17406119
7.

Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM).

Theiss HD, David R, Engelmann MG, Barth A, Schotten K, Naebauer M, Reichart B, Steinbeck G, Franz WM.

Eur Heart J. 2007 May;28(10):1258-64. Epub 2007 Mar 29.

PMID:
17395679
8.

Stem cell therapy after myocardial infarction: ready for clinical application?

Engelmann MG, Franz WM.

Curr Opin Mol Ther. 2006 Oct;8(5):396-414. Review.

PMID:
17078382
9.
10.

Chronic perivascular inoculation with Chlamydophila pneumoniae results in plaque formation in vivo.

Engelmann MG, Redl CV, Pelisek J, Barz C, Heesemann J, Nikol S.

Lab Invest. 2006 May;86(5):467-76.

11.

Phase-sensitive inversion-recovery MR imaging in the detection of myocardial infarction.

Huber AM, Schoenberg SO, Hayes C, Spannagl B, Engelmann MG, Franz WM, Reiser MF.

Radiology. 2005 Dec;237(3):854-60.

PMID:
16304107
12.

Pulmonary abscess with bacteremia in a young man.

Engelmann MG, Nikol S, Vogelmeier C.

CMAJ. 2004 Aug 3;171(3):233. No abstract available.

15.

Comparison of surgical versus endovascular occlusion models in pig femoral arteries.

Engelmann MG, Shimizu M, Pelisek J, Fuchs A, Golda A, Mekkaoui C, Fraunberger P, Rolland PH, Nikol S.

J Endovasc Ther. 2004 Feb;11(1):71-9.

PMID:
14748626
16.

Vascular endothelial growth factor response in porcine coronary and peripheral arteries using nonsurgical occlusion model, local delivery, and liposome-mediated gene transfer.

Pelisek J, Fuchs A, Engelmann MG, Shimizu M, Golda A, Mekkaoui C, Rolland PH, Nikol S.

Endothelium. 2003;10(4-5):247-55.

PMID:
14660085
17.

Vascular endothelial growth factor (VEGF165) and its influence on angiogenesis versus arteriogenesis in different vascular beds.

Nikol S, Pelisek J, Engelmann MG, Shimizu M, Fuchs A, Golda A, Armeanu S, Mekkaoui C, Rolland PH.

J Endovasc Ther. 2002 Dec;9(6):842-54.

PMID:
12546587
18.

Optimization of nonviral transfection: variables influencing liposome-mediated gene transfer in proliferating vs. quiescent cells in culture and in vivo using a porcine restenosis model.

Pelisek J, Engelmann MG, Golda A, Fuchs A, Armeanu S, Shimizu M, Mekkaoui C, Rolland PH, Nikol S.

J Mol Med (Berl). 2002 Nov;80(11):724-36. Epub 2002 Oct 24.

PMID:
12436349
19.

Local perivascular application of low amounts of a plasmid encoding for vascular endothelial growth factor (VEGF165) is efficient for therapeutic angiogenesis in pigs.

Nikol S, Engelmann MG, Pelisek J, Fuchs A, Golda A, Shimizu M, Mekkaoui C, Rolland PH.

Acta Physiol Scand. 2002 Oct;176(2):151-9.

PMID:
12354175
20.

[Therapeutic neoangiogenesis. Alternative or adjuvant option in the treatment of advanced coronary and peripheral ischemic vascular disease].

Engelmann MG, Nikol S.

Dtsch Med Wochenschr. 2001 Sep 21;126(38):1053-7. Review. German. No abstract available.

PMID:
11565060
21.

Evaluation of endovascular techniques for creating a porcine femoral artery occlusion model.

Nikol S, Armeanu S, Engelmann MG, Pelisek J, Fuchs A, Zähringer C, Bartoli JM, Mesana T, Rolland PH.

J Endovasc Ther. 2001 Aug;8(4):401-7.

PMID:
11552732
22.

In vivo perivascular implantation of encapsulated packaging cells for prolonged retroviral gene transfer.

Armeanu S, Haessler I, Saller R, Engelmann MG, Heinemann F, Krausz E, Stange J, Mitzner S, Salmons B, Günzburg WH, Nikol S.

J Microencapsul. 2001 Jul-Aug;18(4):491-506.

PMID:
11428678
23.

Non-invasive coronary bypass graft imaging after multivessel revascularisation.

Engelmann MG, Knez A, von Smekal A, Wintersperger BJ, Huehns TY, Höfling B, Reiser MF, Steinbeck G.

Int J Cardiol. 2000 Oct;76(1):65-74.

PMID:
11121598
24.

[Therapeutic neoangiogenesis of peripheral arteries].

Engelmann MG, Nikol S.

Herz. 2000 Sep;25(6):600-10. Review. German.

PMID:
11076318
25.

Prevention of Restenosis Using the Gene for Cecropin Complexed with DOCSPER Liposomes under Optimized Conditions.

Nikol S, Pelisek J, Engelmann MG, Rolland PH, Armeanu S.

Int J Angiol. 2000 Mar;9(2):87-94.

PMID:
10758203
26.

Needle injection catheter delivery of the gene for an antibacterial agent inhibits neointimal formation.

Nikol S, Huehns TY, Krausz E, Armeanu S, Engelmann MG, Winder D, Salmons B, Hoefling B.

Gene Ther. 1999 May;6(5):737-48.

27.

Neointimal growth can be influenced by local adventitial gene manipulation via a needle injection catheter.

Huehns TY, Krausz E, Mrochen S, Schmid M, Engelmann MG, Esin S, Schrittenloher PK, Höfling B, Günzburg WH, Nikol S.

Atherosclerosis. 1999 May;144(1):135-50.

PMID:
10381287
28.

Patency of coronary bypass grafts: assessment with breath-hold contrast-enhanced MR angiography--value of a non-electrocardiographically triggered technique.

Wintersperger BJ, Engelmann MG, von Smekal A, Knez A, Penzkofer HV, Höfling B, Laub G, Reiser MF.

Radiology. 1998 Aug;208(2):345-51.

PMID:
9680557
29.

[Contrast media enhanced magnetic resonance angiography for determining patency of a coronary bypass. A comparison with coronary angiography].

Wintersperger BJ, von Smekal A, Engelmann MG, Knez A, Penzkofer HV, Laub G, Reiser M.

Rofo. 1997 Dec;167(6):572-8. German.

PMID:
9465951
30.

Accuracy of spiral computed tomography for identifying arterial and venous coronary graft patency.

Engelmann MG, von Smekal A, Knez A, Kürzinger E, Huehns TY, Höfling B, Reiser M.

Am J Cardiol. 1997 Sep 1;80(5):569-74.

PMID:
9294983

Supplemental Content

Loading ...
Support Center